Operating Expenses
Other Segment Items
Pfizer Other Segment Items increased by 80.9% to -$861.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from -$953.00M to -$861.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ2 2020
Last reportedQ1 2026
How to read this metric
An increase in income signals positive non-operating performance, while an increase in expense signals drag from peripheral activities.
Detailed definition
This metric captures miscellaneous income or expense items that are not directly related to the core operational activit...
Peer comparison
Similar to 'Other Income/Expense' found in standard income statements; peers often group these items to isolate core operating margin.
Metric ID:
is_mrk_other_segment_itemsHistorical Data
12 periods
| Q3 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $59.00M | $75.00M | $79.00M | -$680.00M | -$1.11B | -$243.00M | -$2.36B | -$953.00M | -$739.00M | -$517.00M | -$4.52B | -$861.00M |
| QoQ Change | — | +27.1% | +5.3% | -960.8% | -62.8% | +78.0% | -870.4% | +59.6% | +22.5% | +30.0% | -773.3% | +80.9% |
| YoY Change | — | — | +33.9% | — | <-999% | -407.6% | — | -40.1% | +33.2% | -112.8% | -91.5% | +9.7% |
Range-$4.52B – $79.00M
CAGR+165.0%
Avg YoY Growth-268.9%
Median YoY Growth-65.8%
Other Segment Items at Other Companies
Frequently Asked Questions
- What is Pfizer's other segment items?
- Pfizer (PFE) reported other segment items of -$861.00M in Q1 2026.
- How has Pfizer's other segment items changed year-over-year?
- Pfizer's other segment items increased by 9.7% year-over-year, from -$953.00M to -$861.00M.
- What does other segment items mean?
- Financial gains or losses that fall outside of the company's primary business operations.